U.S. Markets closed

Darzalex Could Boost JNJ’s Revenue Growth in 2018

Daniel Collins
Darzalex Could Boost JNJ’s Revenue Growth in 2018

Johnson & Johnson’s (JNJ) Darzalex generated revenues of $432.0 million in the first quarter compared to $255.0 million in the first quarter of 2017, reflecting ~69.4% YoY (year-over-year) growth.